ネビラピン
↑ “WHO Model List of EssentialMedicines”. World Health Organization (2013年10月). 2014年4月22日閲覧。
1 2 “A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study”. JAMA 279 (12): 930–7. (Mar 1998). doi:10.1001/jama.279.12.930. PMID 9544767. http://jama.ama-assn.org/cgi/reprint/279/12/930.
↑ “A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients”. AIDS 17 (7): 987–99. (May 2003). doi:10.1097/00002030-200305020-00007. PMID 12700448.
↑ “A randomized clinical trial comparing nelfinavir or nevirapine associated to zidovudine/lamivudine in HIV-infected naive patients (the Combine Study)”.
N Engl J Med 351: 217-28
↑ The HIVNET 012 Study and the Safety and Effectiveness of Nevirapine in Preventing Mother-to-Infant Transmission of HIV, http://www3.niaid.nih.gov/news/newsreleases/2004/hivnet012.htm
↑ Celia Farber, "Out of Control: AIDS and the Corruption of Science" http://www.harpers.org/archive/2006/03/0080961
↑ Crane, J 2010, 'Adverse events and placebo effects: African scientists, HIV, and ethics in the 'global health sciences, Social Studies Of Science, 40, 6, pp. 843-870 http://sss.sagepub.com.ezp.lib.unimelb.edu.au/content/40/6/843.full.pdf+html
↑ Lock, M. & Nguyen, V 2010, an Anthropology of Biomedicine, Malden, Wiley-Blackwell.
↑ http://clinicaltrials.gov/show/NCT00074412